Home News Drug Discovery & Development

Drug Discovery & Development

Panav Bio-Tech Introduces Classical Swine Fever – Himmvac Hog Cholera (T/C) Vaccine in India

New Delhi, December 06, 2018: Panav Bio-Tech, a leading company in the animal healthcare, is now offering a vaccine for classical swine fever or Hog Cholera in India. Panav Bio-Tech has a diverse portfolio of Bio-preparation that consists of vaccines that...

France Telemedicine Outlook to 2022: Ken Research

New Delhi, November 17, 2018: The report titled “France Telemedicine Outlook to 2022- By Services and Technology, By Service Platform (Telehealth & M-Health, Telehospitals & Clinics), By Clinical Applications (Telemonitoring, Teleconsultation, Teleassistance, Teleexpertise and Others)” provides a comprehensive analysis...

MedGenome study suggests a personalized cancer vaccine approach to treat Lynch Syndrome

National, September 06, 2018: A breakthrough study on ‘cancer vaccine approach for personalized treatment of Lynch Syndrome’ by MedGenome was published in Scientific Reports this month. The published study in collaboration with Kailash Cancer Hospital and Research Center (KCHRC),...

Cadila Healthcare divests its entire stake in Bremer Pharma, Germany

Mumbai, April 20, 2018: Cadila Healthcare said that company has divested its entire shareholding in Bremer Pharma GmbH, Germany (Bremer), a wholly owned subsidiary of the company and consequently, Bremer ceased to be a subsidiary of the company. The company received...

New potential breast cancer drug identified

New Delhi, April 20,  2018: Scientists, including an Indian-American researcher, have identified a molecule that can help treat breast cancer, giving hope to patients who have become resistant to traditional therapies. The first-in-class molecule shuts down oestrogen-sensitive breast cancer in...

Nifty Pharma index in the red; Cipla, Lupin top drags 

New Delhi, November 27, 2017: Pharma stocks CiplaBSE -0.46 % (down 1.70 per cent), GlaxoSmithKline PharmaceuticalsBSE -0.79 % (down 0.92 per cent) and LupinBSE 0.30 % (down 0.42 per cent) were trading down in afternoon trade on Monday, dragging the...

India Eyes Barter For Drugs for African Countries Hit By Weak Oil Prices by...

New Delhi, June 24, 2016: Indian drugmakers see a barter model as a competitive path forward to keep sales flowing to emerging market countries in Africa hit by weak oil prices, building on efforts already underway on that front...

Cipla inks third respiratory deal in less than a week

In pact with Biopharm to set up company in Algeria Mumbai, Feb 17, 2015 : Drugmaker Cipla has inked its third deal in less than a week, all aimed at beefing up its capacity in the respiratory products segment. On Friday, Cipla...

Ipca’s MP plant hit by ‘import alert’ from US drug regulator

Stock dips over8 per cent on BSE Mumbai, Jan 30, 2015 - Drugmaker Ipca Laboratories Ltd has received an “import alert” from the US Food and Drug Administration banning products from its manufacturing facility in Ratlam, Madhya Pradesh. The facility had received...

Decontrolling drug prices: SC refuses to interfere

New Delhi, October 2014 - The Supreme Court on Monday refused to interfere with the Centre's decision to decontrol prices of 108 cardiac and diabetes drugs saying the issue can be raised before the competent authority through representation. "You approach...